Chemoprevention utility of silibinin and Cdk4 pathway inhibition in Apc-/+ mice

Baktiar O. Karim, Kijong Rhee, Guosheng Liu, Dongfeng Zheng, David L. Huso

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background: Colorectal cancer (CRC) is the second leading cause of death from cancer in the United States. Colorectal cancers have a prolonged latency following initiation that may span decades providing ample time for implementing a chemoprevention strategy that could block or reverse the progression to CRC. Cdk4 pathway alterations have been linked to a number of cancers including CRC. In these experiments we focused on the Cdk4 pathway and its role in intestinal tumorigenesis as a possible target in chemoprevention strategies. Methods: We evaluated the effect of Cdk4 blockade on the prevention of intestinal tumor formation by crossing Cdk4-/- mice to Apc-/+ mice. In addition, we tested the effect of the dietary compound silibinin on the Cdk4 pathway in Apc-/+ mice and HT-29 colon cancer cells in culture. Results: Cdk4-/- mice backcrossed to Apc-/+ mice reduced intestinal adenoma formation compared to Apc-/+ controls. Silibinin effectively targeted the Cdk4 pathway causing hypophosphorylation of the retinoblastoma protein, inhibited cell growth, and induced apoptosis. As a result silibinin blocked the development of intestinal adenomas by 52% in this genetic model (Apc-/+ mice) of early events in colorectal cancer formation. No toxic abnormalities were detected in mice which received silibinin. Conclusions: Modification of the Cdk4 pathway using a natural plant-derived compound such as silibinin may be a useful chemopreventive strategy for colorectal carcinomas.

Original languageEnglish
Article number157
JournalBMC cancer
Volume13
DOIs
Publication statusPublished - 2013 Mar 27

Fingerprint

Chemoprevention
Colorectal Neoplasms
Adenoma
Neoplasms
Retinoblastoma Protein
Poisons
Genetic Models
Phytochemicals
silybin
Colonic Neoplasms
Cause of Death
Carcinogenesis
Cell Culture Techniques
Apoptosis
Growth

All Science Journal Classification (ASJC) codes

  • Oncology
  • Genetics
  • Cancer Research

Cite this

Karim, Baktiar O. ; Rhee, Kijong ; Liu, Guosheng ; Zheng, Dongfeng ; Huso, David L. / Chemoprevention utility of silibinin and Cdk4 pathway inhibition in Apc-/+ mice. In: BMC cancer. 2013 ; Vol. 13.
@article{00cb58249e16449fb1c501c0a8fb8c9b,
title = "Chemoprevention utility of silibinin and Cdk4 pathway inhibition in Apc-/+ mice",
abstract = "Background: Colorectal cancer (CRC) is the second leading cause of death from cancer in the United States. Colorectal cancers have a prolonged latency following initiation that may span decades providing ample time for implementing a chemoprevention strategy that could block or reverse the progression to CRC. Cdk4 pathway alterations have been linked to a number of cancers including CRC. In these experiments we focused on the Cdk4 pathway and its role in intestinal tumorigenesis as a possible target in chemoprevention strategies. Methods: We evaluated the effect of Cdk4 blockade on the prevention of intestinal tumor formation by crossing Cdk4-/- mice to Apc-/+ mice. In addition, we tested the effect of the dietary compound silibinin on the Cdk4 pathway in Apc-/+ mice and HT-29 colon cancer cells in culture. Results: Cdk4-/- mice backcrossed to Apc-/+ mice reduced intestinal adenoma formation compared to Apc-/+ controls. Silibinin effectively targeted the Cdk4 pathway causing hypophosphorylation of the retinoblastoma protein, inhibited cell growth, and induced apoptosis. As a result silibinin blocked the development of intestinal adenomas by 52{\%} in this genetic model (Apc-/+ mice) of early events in colorectal cancer formation. No toxic abnormalities were detected in mice which received silibinin. Conclusions: Modification of the Cdk4 pathway using a natural plant-derived compound such as silibinin may be a useful chemopreventive strategy for colorectal carcinomas.",
author = "Karim, {Baktiar O.} and Kijong Rhee and Guosheng Liu and Dongfeng Zheng and Huso, {David L.}",
year = "2013",
month = "3",
day = "27",
doi = "10.1186/1471-2407-13-157",
language = "English",
volume = "13",
journal = "BMC Cancer",
issn = "1471-2407",
publisher = "BioMed Central",

}

Chemoprevention utility of silibinin and Cdk4 pathway inhibition in Apc-/+ mice. / Karim, Baktiar O.; Rhee, Kijong; Liu, Guosheng; Zheng, Dongfeng; Huso, David L.

In: BMC cancer, Vol. 13, 157, 27.03.2013.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Chemoprevention utility of silibinin and Cdk4 pathway inhibition in Apc-/+ mice

AU - Karim, Baktiar O.

AU - Rhee, Kijong

AU - Liu, Guosheng

AU - Zheng, Dongfeng

AU - Huso, David L.

PY - 2013/3/27

Y1 - 2013/3/27

N2 - Background: Colorectal cancer (CRC) is the second leading cause of death from cancer in the United States. Colorectal cancers have a prolonged latency following initiation that may span decades providing ample time for implementing a chemoprevention strategy that could block or reverse the progression to CRC. Cdk4 pathway alterations have been linked to a number of cancers including CRC. In these experiments we focused on the Cdk4 pathway and its role in intestinal tumorigenesis as a possible target in chemoprevention strategies. Methods: We evaluated the effect of Cdk4 blockade on the prevention of intestinal tumor formation by crossing Cdk4-/- mice to Apc-/+ mice. In addition, we tested the effect of the dietary compound silibinin on the Cdk4 pathway in Apc-/+ mice and HT-29 colon cancer cells in culture. Results: Cdk4-/- mice backcrossed to Apc-/+ mice reduced intestinal adenoma formation compared to Apc-/+ controls. Silibinin effectively targeted the Cdk4 pathway causing hypophosphorylation of the retinoblastoma protein, inhibited cell growth, and induced apoptosis. As a result silibinin blocked the development of intestinal adenomas by 52% in this genetic model (Apc-/+ mice) of early events in colorectal cancer formation. No toxic abnormalities were detected in mice which received silibinin. Conclusions: Modification of the Cdk4 pathway using a natural plant-derived compound such as silibinin may be a useful chemopreventive strategy for colorectal carcinomas.

AB - Background: Colorectal cancer (CRC) is the second leading cause of death from cancer in the United States. Colorectal cancers have a prolonged latency following initiation that may span decades providing ample time for implementing a chemoprevention strategy that could block or reverse the progression to CRC. Cdk4 pathway alterations have been linked to a number of cancers including CRC. In these experiments we focused on the Cdk4 pathway and its role in intestinal tumorigenesis as a possible target in chemoprevention strategies. Methods: We evaluated the effect of Cdk4 blockade on the prevention of intestinal tumor formation by crossing Cdk4-/- mice to Apc-/+ mice. In addition, we tested the effect of the dietary compound silibinin on the Cdk4 pathway in Apc-/+ mice and HT-29 colon cancer cells in culture. Results: Cdk4-/- mice backcrossed to Apc-/+ mice reduced intestinal adenoma formation compared to Apc-/+ controls. Silibinin effectively targeted the Cdk4 pathway causing hypophosphorylation of the retinoblastoma protein, inhibited cell growth, and induced apoptosis. As a result silibinin blocked the development of intestinal adenomas by 52% in this genetic model (Apc-/+ mice) of early events in colorectal cancer formation. No toxic abnormalities were detected in mice which received silibinin. Conclusions: Modification of the Cdk4 pathway using a natural plant-derived compound such as silibinin may be a useful chemopreventive strategy for colorectal carcinomas.

UR - http://www.scopus.com/inward/record.url?scp=84875344694&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875344694&partnerID=8YFLogxK

U2 - 10.1186/1471-2407-13-157

DO - 10.1186/1471-2407-13-157

M3 - Article

VL - 13

JO - BMC Cancer

JF - BMC Cancer

SN - 1471-2407

M1 - 157

ER -